Heart disease is widely perceived as a male problem. It is not. After menopause, cardiovascular disease becomes the leading cause of death in women — surpassing all gynaecological cancers combined. The protection that oestrogen provides to the cardiovascular system is real, and its loss at menopause produces measurable, rapid changes in cardiac risk factors.

This is not something most Indian women are told at their menopause consultation. It should be.

Dr. Shachi Singh, consultant gynaecologist at Prakash Hospital, Sector 33, Noida, explains.

---

Oestrogen's Cardiovascular Protection

Before menopause, women have significantly lower rates of heart attack and stroke than age-matched men. This gap is not primarily lifestyle-driven — it is largely hormonal. Oestrogen has multiple direct cardiovascular effects:

Vasodilatory: Oestrogen promotes production of nitric oxide in blood vessel walls, keeping arteries dilated and reducing resistance. After menopause, this effect is lost — arteries stiffen and resting blood pressure rises.

Lipid profile: Oestrogen raises HDL ("good" cholesterol) and maintains lower LDL ("bad" cholesterol). After menopause, HDL falls and LDL rises — often substantially within the first 2 to 3 years after the final period. This shift in lipid profile directly increases atherosclerosis risk.

Insulin sensitivity: Oestrogen improves insulin sensitivity. Menopause is associated with worsening insulin resistance — increasing type 2 diabetes risk and the atherogenic metabolic profile that accompanies it.

Inflammatory markers: Oestrogen has anti-inflammatory effects. CRP and other inflammatory markers rise after menopause.

Body fat distribution: Before menopause, fat is preferentially deposited in the hips and thighs (gynoid pattern) — this fat is metabolically relatively inert. After menopause, fat redistribution to the abdomen (android/central pattern) increases visceral fat — the most metabolically active and cardiovascular risk-elevating type.

---

What Happens to Risk Factors at Menopause

In the years around the final menstrual period, multiple cardiovascular risk factors worsen simultaneously:

• Blood pressure rises — hypertension becomes much more common in postmenopausal women
• LDL cholesterol rises — often by 10 to 20% within the first two years
• Blood glucose rises — type 2 diabetes incidence increases sharply after menopause
• Central adiposity increases — even in women who do not gain overall weight, fat shifts centrally
• Arterial stiffness increases
• Fibrinogen (clotting factor) rises

This is a simultaneous, multi-system deterioration in cardiovascular risk profile — and it is why a woman who had completely normal cardiovascular health at 48 can have hypertension, elevated cholesterol, and pre-diabetes at 55, without any change in lifestyle.

---

Premature Menopause and Cardiovascular Risk

Women who experience premature menopause — before age 40 — or early menopause (before 45) have a substantially elevated cardiovascular risk compared to women who reach natural menopause at the average Indian age of 46 to 47. Decades of oestrogen deprivation significantly accelerate cardiovascular aging.

This is one of the main reasons HRT is specifically recommended for women with premature ovarian insufficiency or premature menopause — not just for symptom relief, but as cardiovascular protection until the age of natural menopause.

---

The Evidence on HRT and Cardiovascular Risk

The "timing hypothesis" is now well-established: starting HRT within 10 years of menopause (or before age 60) in women without pre-existing cardiovascular disease appears to reduce — not increase — cardiovascular risk. This is the opposite of the conclusion drawn from the 2002 WHI study, which used older women (average age 63), started treatment more than 10 years after menopause, and used an oral progestogen (medroxyprogesterone acetate) with adverse cardiovascular properties.

Transdermal oestrogen specifically — avoiding first-pass liver metabolism — does not raise clotting risk and appears to have more favourable cardiovascular effects than oral oestrogen.

For healthy women in the menopause transition who start HRT promptly and use modern formulations (transdermal oestrogen, micronised progesterone), the cardiovascular data is reassuring — and potentially protective.

---

What Every Perimenopausal and Postmenopausal Woman Should Monitor

The standard well-woman check after 45 to 50 should include:

• Blood pressure: Target below 130/80 mmHg
• Fasting lipid profile: Total cholesterol, LDL, HDL, triglycerides — annually or more frequently if elevated
• Fasting blood glucose and HbA1c: Diabetes screening
• Body weight and waist circumference: Waist above 80 cm in women signals central adiposity risk
• Thyroid function: Hypothyroidism is common after 40 and worsens lipid profile

---

What to Do: Practical Cardiovascular Protection After Menopause

Exercise: The most potent cardiovascular intervention available. 150 minutes of moderate aerobic activity weekly — brisk walking, swimming, cycling — reduces cardiovascular risk by approximately 30 to 40%. Resistance training twice weekly improves glucose metabolism and preserves lean mass.

Diet: Mediterranean-style diet principles apply across populations — vegetables, legumes, whole grains, limited processed food and refined carbohydrate, limited saturated fat. For Indian women: less refined grain (maida), more dal and sabzi, limited fried and packaged food.

Weight: Even modest weight loss (5%) in overweight women significantly improves blood pressure, glucose, and lipid profile.

Smoking cessation: Women who smoke reach menopause approximately 1 to 2 years earlier than non-smokers — and smoking dramatically amplifies all cardiovascular risk factors after menopause.

HRT discussion: For women within 10 years of menopause onset with moderate to severe symptoms, the cardiovascular risk-benefit calculation may actually favour HRT — discuss with your gynaecologist.

---

Gynaecological Care in Noida and Greater Noida

Dr. Shachi Singh at Prakash Hospital, Sector 33, Noida, provides menopause management with attention to cardiovascular health for women across Noida and Greater Noida.

To book a consultation, call: +91 97023 46853

Clinic Hours: Monday to Saturday, 9 AM – 6 PM | Sunday, 10 AM – 2 PM

Address: D-12A, 12B, Sector-33, G.B. Nagar, Noida, UP 201301

---

This blog is for educational purposes only. Cardiovascular risk management should be individualised with your physician.